febuxostat   Click here for help

GtoPdb Ligand ID: 6817

Synonyms: Adenuric® | MX-67 | Tei 6720 | Tei-6720 | TMX 67 | Uloric®
Approved drug PDB Ligand
febuxostat is an approved drug (EMA & FDA (2009))
Compound class: Synthetic organic
Comment: Inhibits xanthine dehydrogenase
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 111.45
Molecular weight 316.09
XLogP 2.67
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1cc(ccc1OCC(C)C)c1nc(c(s1)C(=O)O)C
Isomeric SMILES N#Cc1cc(ccc1OCC(C)C)c1nc(c(s1)C(=O)O)C
InChI InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)
InChI Key BQSJTQLCZDPROO-UHFFFAOYSA-N
References
1. Evenäs J, Edfeldt F, Lepistö M, Svitacheva N, Synnergren A, Lundquist B, Gränse M, Rönnholm A, Varga M, Wright J et al.. (2014)
HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase.
Bioorg Med Chem Lett, 24 (5): 1315-21. [PMID:24508129]
2. Khanna S, Burudkar S, Bajaj K, Shah P, Keche A, Ghosh U, Desai A, Srivastava A, Kulkarni-Almeida A, Deshmukh NJ et al.. (2012)
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia.
Bioorg Med Chem Lett, 22 (24): 7543-6. [PMID:23122864]
3. Okamoto K, Eger BT, Nishino T, Kondo S, Pai EF, Nishino T. (2003)
An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition.
J Biol Chem, 278 (3): 1848-55. [PMID:12421831]